Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mesa Laboratories, Inc. (MLAB : NSDQ)

• Company Description    MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. Number of Employees: 730

• Price / Volume Information    Yesterday's Closing Price: $76.01 Daily Weekly Monthly 20 Day Moving Average: 96,341 shares Shares Outstanding: 5.50 (millions) Market Capitalization: $418.17 (millions) Beta: 0.89 52 Week High: $155.12 52 Week Low: $55.45 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 12.23% 9.28% 12 Week 10.37% 5.79% Year To Date -42.36% -49.62%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12100 W 6TH AVE - LAKEWOOD,CO 80228 USA ph: 303-987-8000 fax: 303-987-8989 investorrelations@mesalabs.com http://www.mesalabs.com

• General Corporate Information    Officers Gary M. Owens - Chief Executive Officer; President; and Director John J. Sullivan - Chairman of the Board of Directors John V. Sakys - Chief Financial Officer and Chief Accounting Offic Jennifer S. Alltoft - Director Mark C. Capone - Director Peer Information Mesa Laboratories, Inc. (ABMD) Mesa Laboratories, Inc. (DMDS) Mesa Laboratories, Inc. (CPWY.) Mesa Laboratories, Inc. (EQUR) Mesa Laboratories, Inc. (ECIA) Mesa Laboratories, Inc. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 59064R109 SIC: 3823 Fiscal Year Fiscal Year End: March Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/03/26 Share - Related Items Shares Outstanding: 5.50 Most Recent Split Date: (:1) Beta: 0.89 Market Capitalization: $418.17 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.84% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.64 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: 0.10 Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: -0.01 Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: 08/29/2025 - $0.16 Next EPS Report Date: 02/03/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: 11.59 PEG Ratio: - Price Ratios Price/Book: 2.34 Price/Cash Flow: 6.20 Price / Sales: 1.71 EPS Growth vs. Year Ago Period: -32.60% vs. Previous Quarter: -24.69% Sales Growth vs. Year Ago Period: 5.02% vs. Previous Quarter: 2.01% ROE 09/30/25 - 21.59 06/30/25 - 24.49 03/31/25 - 27.51 ROA 09/30/25 - 8.28 06/30/25 - 9.03 03/31/25 - 9.78 Current Ratio 09/30/25 - 2.02 06/30/25 - 0.66 03/31/25 - 0.63 Quick Ratio 09/30/25 - 1.44 06/30/25 - 0.47 03/31/25 - 0.47 Operating Margin 09/30/25 - 14.66 06/30/25 - 16.40 03/31/25 - 17.90 Net Margin 09/30/25 - -0.64 06/30/25 - -0.26 03/31/25 - -0.82 Pre-Tax Margin 09/30/25 - 2.96 06/30/25 - 3.74 03/31/25 - 2.47 Book Value 09/30/25 - 32.44 06/30/25 - 31.35 03/31/25 - 29.42 Inventory Turnover 09/30/25 - 3.40 06/30/25 - 3.30 03/31/25 - 3.13 Debt-to-Equity 09/30/25 - 0.95 06/30/25 - 0.46 03/31/25 - 0.48 Debt-to-Capital 09/30/25 - 48.81 06/30/25 - 31.56 03/31/25 - 32.49

Powered by Zacks Investment Research ©